These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2202802)

  • 1. Glucose therapy for glycogenosis type 1 in infants: comparison of intermittent uncooked cornstarch and continuous overnight glucose feedings.
    Wolfsdorf JI; Keller RJ; Landy H; Crigler JF
    J Pediatr; 1990 Sep; 117(3):384-91. PubMed ID: 2202802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dietary interventions in the maintenance of normoglycaemia in glycogen storage disease type 1a: a systematic review and meta-analysis.
    Shah KK; O'Dell SD
    J Hum Nutr Diet; 2013 Aug; 26(4):329-39. PubMed ID: 23294025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous glucose for treatment of patients with type 1 glycogen-storage disease: comparison of the effects of dextrose and uncooked cornstarch on biochemical variables.
    Wolfsdorf JI; Plotkin RA; Laffel LM; Crigler JF
    Am J Clin Nutr; 1990 Dec; 52(6):1043-50. PubMed ID: 2239779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of continuous glucose therapy begun in infancy on the long-term clinical course of patients with type I glycogen storage disease.
    Wolfsdorf JI; Crigler JF
    J Pediatr Gastroenterol Nutr; 1999 Aug; 29(2):136-43. PubMed ID: 10435649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical growth and development of children with type 1 glycogen-storage disease: comparison of the effects of long-term use of dextrose and uncooked cornstarch.
    Wolfsdorf JI; Rudlin CR; Crigler JF
    Am J Clin Nutr; 1990 Dec; 52(6):1051-7. PubMed ID: 2239780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cornstarch treatment in very young children with type I glycogen storage disease.
    Hayde M; Widhalm K
    Eur J Pediatr; 1990 Jun; 149(9):630-3. PubMed ID: 2373114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type I glycogen storage disease: nine years of management with cornstarch.
    Chen YT; Bazzarre CH; Lee MM; Sidbury JB; Coleman RA
    Eur J Pediatr; 1993; 152 Suppl 1():S56-9. PubMed ID: 8319727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal daytime feeding regimen to prevent postprandial hypoglycemia in type 1 glycogen storage disease.
    Wolfsdorf JI; Ehrlich S; Landy HS; Crigler JF
    Am J Clin Nutr; 1992 Sep; 56(3):587-92. PubMed ID: 1503073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous nocturnal intragastric feeding for management of type 1 glycogen-storage disease.
    Greene HL; Slonim AE; O'Neill JA; Burr IM
    N Engl J Med; 1976 Feb; 294(8):423-5. PubMed ID: 813144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Type I glycogenosis: extending therapy with uncooked cornstarch].
    Biggemann B; Hilgarth R; Wendel U
    Monatsschr Kinderheilkd; 1986 Mar; 134(3):142-5. PubMed ID: 3084952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1a glycogen storage disease.
    Weinstein DA; Wolfsdorf JI
    Eur J Pediatr; 2002 Oct; 161 Suppl 1():S35-9. PubMed ID: 12373568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical evidence for the requirement of continuous glucose therapy in young adults with type 1 glycogen storage disease.
    Wolfsdorf JI; Crigler JF
    J Inherit Metab Dis; 1994; 17(2):234-41. PubMed ID: 7967479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen storage disease type Ia: linkage of glucose, glycogen, lactic acid, triglyceride, and uric acid metabolism.
    Sever S; Weinstein DA; Wolfsdorf JI; Gedik R; Schaefer EJ
    J Clin Lipidol; 2012; 6(6):596-600. PubMed ID: 23312056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutrition therapy for hepatic glycogen storage diseases.
    Goldberg T; Slonim AE
    J Am Diet Assoc; 1993 Dec; 93(12):1423-30. PubMed ID: 8245377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intragastric feeding in type I glycogen storage disease: factors affecting the control of lactic acidemia.
    Stanley CA; Mills JL; Baker L
    Pediatr Res; 1981 Dec; 15(12):1504-8. PubMed ID: 6798537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of waxy maize heat modified starch in the treatment of children between 2 and 5 years with glycogen storage disease type I: A retrospective study.
    Hijazi G; Pai N; Nagy LL; Herd S; Dickson J; Ram M; Inbar-Feigenberg M
    Mol Genet Metab Rep; 2019 Dec; 21():100536. PubMed ID: 31844626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dietary treatment of children with type I glycogen storage disease with slow release carbohydrate.
    Smit GP; Berger R; Potasnick R; Moses SW; Fernandes J
    Pediatr Res; 1984 Sep; 18(9):879-81. PubMed ID: 6384910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of modified cornstarch therapy to extend fasting in glycogen storage disease types Ia and Ib.
    Correia CE; Bhattacharya K; Lee PJ; Shuster JJ; Theriaque DW; Shankar MN; Smit GP; Weinstein DA
    Am J Clin Nutr; 2008 Nov; 88(5):1272-6. PubMed ID: 18996862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative nighttime nutrition regimens in glycogen storage disease type I: a controlled crossover study.
    Hochuli M; Christ E; Meienberg F; Lehmann R; Krützfeldt J; Baumgartner MR
    J Inherit Metab Dis; 2015 Nov; 38(6):1093-8. PubMed ID: 26109257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvements of hypertriglyceridemia and hyperlacticemia in Japanese children with glycogen storage disease type Ia by medium-chain triglyceride milk.
    Nagasaka H; Hirano K; Ohtake A; Miida T; Takatani T; Murayama K; Yorifuji T; Kobayashi K; Kanazawa M; Ogawa A; Takayanagi M
    Eur J Pediatr; 2007 Oct; 166(10):1009-16. PubMed ID: 17206455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.